Literature DB >> 7970124

Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.

V Frémeaux-Bacchi1, L Weiss, P Brun, M D Kazatchkine.   

Abstract

The serum of patients with membranoproliferative glomerulonephritis (MPGN) often exhibits C3 nephritic factor activity (C3NeF) associated with autoantibodies directed against the C3bBb alternative complement pathway C3 convertase. In the present study, we have sequentially assessed C3NeF activity in the purified IgG fraction of the serum of a patient with MPGN type II and end-stage renal disease every month for 1 year following renal transplantation and bilateral nephrectomy. C3NeF activity in the patient's purified serum IgG decreased with time from the first month after transplantation and became undetectable after forty-five weeks. At that time, plasma levels of C3 and factor B had returned to normal values. The disappearance of C3NeF activity in patient's IgG was selective in that no change in activity of two other autoantibodies and of one antibody against a non-self antigen was observed with time, indicating that the decrease in C3NeF activity was not related to a non-specific effect of immunosuppressive therapy. Loss of C3NeF activity was not related to the generation of anti-idiotypic antibodies against C3NeF. This study documents for the first time the selective disappearance of C3NeF activity following renal transplantation and bilateral nephrectomy. The results suggest that the autoantibody represents an antigen-driven expansion of self reactive B cell clones in response to a specific disease process in the kidney of patients with MPGN.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7970124

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  13 in total

1.  Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.

Authors:  Serena Bettoni; Elena Bresin; Giuseppe Remuzzi; Marina Noris; Roberta Donadelli
Journal:  J Biol Chem       Date:  2016-02-22       Impact factor: 5.157

Review 2.  C3 Glomerulopathy.

Authors:  Magdalena Riedl; Paul Thorner; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-04-07       Impact factor: 3.714

Review 3.  Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.

Authors:  Marina Noris; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Pediatr Nephrol       Date:  2018-06-09       Impact factor: 3.714

4.  Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN.

Authors:  Maria Chiara Marinozzi; Lubka T Roumenina; Sophie Chauvet; Alexandre Hertig; Dominique Bertrand; Jérome Olagne; Marie Frimat; Tim Ulinski; Georges Deschênes; Stephane Burtey; Michel Delahousse; Bruno Moulin; Christophe Legendre; Véronique Frémeaux-Bacchi; Moglie Le Quintrec
Journal:  J Am Soc Nephrol       Date:  2017-01-17       Impact factor: 10.121

5.  Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donor.

Authors:  G Sturfelt; S Lenhoff; B Sallerfors; O Nived; L Truedsson; A G Sjöholm
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

6.  Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.

Authors:  Paraskevas Iatropoulos; Erica Daina; Manuela Curreri; Rossella Piras; Elisabetta Valoti; Caterina Mele; Elena Bresin; Sara Gamba; Marta Alberti; Matteo Breno; Annalisa Perna; Serena Bettoni; Ettore Sabadini; Luisa Murer; Marina Vivarelli; Marina Noris; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2017-10-13       Impact factor: 10.121

Review 7.  Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.

Authors:  M Noris; G Remuzzi
Journal:  Clin Exp Immunol       Date:  2007-12-07       Impact factor: 4.330

8.  C3 nephritic factor associated with C3 glomerulopathy in children.

Authors:  Camille Nicolas; Vincent Vuiblet; Veronique Baudouin; Marie-Alice Macher; Isabele Vrillon; Nathalie Biebuyck-Gouge; Maud Dehennault; Sophie Gié; Denis Morin; Hubert Nivet; François Nobili; Tim Ulinski; Bruno Ranchin; Maria Chiarra Marinozzi; Stéphanie Ngo; Véronique Frémeaux-Bacchi; Christine Pietrement
Journal:  Pediatr Nephrol       Date:  2013-09-26       Impact factor: 3.714

Review 9.  New approaches to the treatment of dense deposit disease.

Authors:  Richard J H Smith; Jessy Alexander; Paul N Barlow; Marina Botto; Thomas L Cassavant; H Terence Cook; Santiago Rodriguez de Córdoba; Gregory S Hageman; T Sakari Jokiranta; William J Kimberling; John D Lambris; Lynne D Lanning; Vicki Levidiotis; Christoph Licht; Hans U Lutz; Seppo Meri; Matthew C Pickering; Richard J Quigg; Angelique L Rops; David J Salant; Sanjeev Sethi; Joshua M Thurman; Hope F Tully; Sean P Tully; Johan van der Vlag; Patrick D Walker; Reinhard Würzner; Peter F Zipfel
Journal:  J Am Soc Nephrol       Date:  2007-08-05       Impact factor: 10.121

10.  Novel factor H mutation associated with familial membranoproliferative glomerulonephritis type I.

Authors:  Hadas Alfandary; Miriam Davidovits
Journal:  Pediatr Nephrol       Date:  2015-08-20       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.